“…Hypermethylation of the promoters has been linked to the down-regulation of these genes in breast, gastric, and colorectal cancers, contributing to tumor growth and invasion [56][57][58][59]. Conversely, hypomethylation of these genes has been observed in ovarian and lung cancers, leading to their overexpression and association with aggressive tumor phenotypes [60,61].…”